Close Menu

This week, PNAS reports on a new method to study small molecule metabolites in C. elegans, especially how they might interact synergistically. Using a NMR-spectroscopic method, differential analysis by 2D NMR spectroscopy (DANS), they were able to compare wild-type C. elegans and a mutant lacking pheromone signaling genes to identify both known and unknown ascarosides – in variable concentrations, these molecules can be both sex pheromones and developmental regulators.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.